Amgen's diverse portfolio ensures stability, but risks like high debt and biosimilar competition loom. Check out my look at AMGN stock after its Q1 earnings.

Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to speculate on the impact of U.S. tariffs, tax policy would be a more effective ...

Amgen AMGN is off to a strong start in 2025 with its first-quarter earnings as well as sales beating estimates. Particularly, ...